← Who reports today · Financials
How CME Group (CME) makes money: Q2 2026 revenue breakdown
US GAAP · $M · vs Q2 2025 · quarter ended 06/30/2026
CME Group Inc., headquartered in Chicago, Illinois, operates exchanges and provides clearing services for trading in financial derivatives such as futures contracts, options, and swaps. · Wikipedia
More about the company
Its exchanges include the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company also owns 27% of S&P Dow Jones Indices. The company operates the Globex Trading System, an electronic trading platform that allows customers in approximately 150 countries to trade futures and options contracts. The company also operates two platforms for spot market trading: BrokerTec, which facilitates dealer-to-dealer trading in fixed-income products, and EBS, which provides spot trading in foreign exchange markets. CME Clearing serves as a counterparty to every transaction cleared by the company.
Key growth driver: Market Data & Information — the fastest-growing revenue line: $238, +20% y/y. · by the Q2 2026 report
How does CME Group make money?
CME Group brought in $1.71 billion of revenue in Q2 2026, up 0.8% year over year. The largest source was Clearing & Transaction Fees: $1.35 billion, or 79% of the total, followed by Market Data & Information ($238M, 14%); other lines add the remaining 7%. Net income for the quarter was $1.04 billion, up 1.6% year over year.
Revenue by source, Q2 2026
- Clearing & Transaction Fees$1.35B · 79% · −2.6%
- Market Data & Information$238M · 14% · +20.2%
- Other Revenues$116M · 7% · +9.2%
Shares of $1.71B total revenue; changes are year over year, as reported. ≈ marks lines derived from disclosed totals. The same flows are drawn in the Sankey chart below.
When is CME’s next earnings date?
Wednesday, October 21, 2026confirmed · before market open
CME Group (CME) is scheduled to report results for the quarter ending Sep 2026 on Oct 21, 2026. Consensus EPS forecast: $2.96 (7 analysts), vs $2.68 in the same quarter last year.
What time does CME report? Usually before market open: the last 4 results releases reached the SEC at 7:15 am, 7:13 am, 7:06 am, 7:05 am ET.
Last report: Jul 24, 2026 (Q2 2026) — broken down in the Sankey chart below. Dates and consensus: Nasdaq / Zacks Investment Research; companies do reschedule. Who else reports this week →
All figures in $M.
Revenue
$1,706
+0.8%
Operating income
$1,107
-2.0%
64.9% margin
Net income
$1,042
+1.6%
$2.88/sh · 61% margin
Verdict: a flat quarter at a very high altitude — clearing fees slipped 2.6% off last year's record volatility-driven volumes, but 20% growth in market data and steady expense discipline kept the 65% operating margin and nudged net income up 1.6%; the exchange monopoly compounds even in quiet markets.
Interest rates remain the biggest product line ($433M fees, −6% off record hedging volumes); equity indexes $324M (+7%). Investment income ($1,430M) is mostly collateral interest passed back to clearing firms ($1,263M) — only the spread stays.
Source and notation
* marks non-cash / ≈ estimated. 'Investment & Other, net' combines investment income, collateral pass-through to clearing firms, JV earnings and borrowing costs. Source: CME Group 10-Q (SEC EDGAR).
Open the chart as a PNG image ↗ · for sharing and presentations · free to reuse, CC BY 4.0
CME earnings history: past report dates
| Jul 22, 2026 Wed | 7:15 ambefore market open | Jun 30, 2026 | $1.7B+1% y/y | $2.88+2% y/y |
| Apr 22, 2026 Wed | 7:13 ambefore market open | Mar 31, 2026 | $1.9B+14% y/y | $3.18+21% y/y |
| Feb 4, 2026 Wed | 7:06 ambefore market open | Dec 31, 2025 | ≈$1.6B+8% y/y | ≈$3.24+35% y/y |
| Oct 22, 2025 Wed | 7:05 ambefore market open | Sep 30, 2025 | $1.5B−3% y/y | $2.49−0% y/y |
| Jul 23, 2025 Wed | 7:08 ambefore market open | Jun 30, 2025 | $1.7B+10% y/y | $2.81+16% y/y |
| Apr 23, 2025 Wed | 7:07 ambefore market open | Mar 31, 2025 | $1.6B+10% y/y | $2.62+11% y/y |
| Feb 12, 2025 Wed | 7:05 ambefore market open | Dec 31, 2024 | ≈$1.5B+6% y/y | ≈$2.40+8% y/y |
| Oct 23, 2024 Wed | 7:06 ambefore market open | Sep 30, 2024 | $1.6B+18% y/y | $2.50+21% y/y |
How we count
Report date and time — when the company filed its results press release with the SEC (Form 8-K, Item 2.02); the regular session runs 9:30 am – 4:00 pm ET. Revenue and diluted EPS — the company’s XBRL filings, EPS adjusted for stock splits; ≈ — fourth quarter derived as full year minus three quarters. Source: SEC EDGAR.
CME Group: 5-year financials
| 2025 | 6,521 | 4,230 | 4,072 | 4,194 | 3,933 |
| 2024 | 6,130 | 3,932 | 3,526 | 3,597 | 3,584 |
| 2023 | 5,579 | 3,436 | 3,226 | 3,377 | 3,236 |
| 2022 | 5,019 | 3,016 | 2,691 | 2,966 | 2,634 |
| 2021 | 4,690 | 2,645 | 2,637 | 2,275 | 2,189 |
$ millions, annual 10-K reports on SEC EDGAR (US GAAP).
How we calculate
Figures are the annual report lines as filed, no adjustments. Free cash flow is operating cash flow minus capital expenditures; dividends are cash paid to common shareholders during the year. “—” means the line isn’t in the filing.
Corporate governance
1.5/2mostly good
How the company treats minority shareholders: 2 — well, 0 — systematically poorly.
More
- Jun 20268-K: on Jun 9, 2026 proposals to eliminate the right of Class B-1 to elect three directors and of Class B-2 to elect two failed (27.8% of B-1 shares voted for, short of the required majority); B-3 lacked a quorum. sec.gov ↗
- Mar 20262026 proxy: the board proposed eliminating Class B director election rights to remove what investors view as a "dual-class" structure. sec.gov ↗
- Feb 202610-K FY2025: 358.6M Class A shares vs. 625/813/1,287 Class B-1/B-2/B-3 shares; annual variable dividend of $6.15 declared on Feb 12, 2026. sec.gov ↗
- Feb 2026Diluted shares 358.5M (2020) → 360.3M (2025), +0.5%. data.sec.gov ↗
Scoring: 2.0 −0.5 (criterion 7: ~3,100 Class B shares held by exchange members elect 6 of ~20 directors, no sunset; no majority; the attempt to eliminate the right failed in Jun 2026) = 1.5; dilution +0.5% over 5 years, regular + variable dividend per policy
- Share classes
- Class B-1/B-2/B-3 (625+813+1,287 shares, tied to trading rights) separately elect 3+2+1 directors; the board's proposal to eliminate this right failed on Jun 9, 2026 (Class B majority not reached) → −0.5.
- Dilution
- Diluted shares 358.5M (2020) → 360.3M (2025), +0.5%; SBC 1.5%; 2021 Series G preferred (Google) — at market, convertible 1:1.
- Disclosure
- Full reporting.
- Dividends
- Regular quarterly dividend + annual variable dividend based on the year's results (for 2025 — $6.15, declared Feb 12, 2026); the 2025 dip in XBRL reflects a shift in the declaration date.
- Lawsuits & regulators
- 10-K FY2025 shows no shareholder suits or SEC cases; CFTC matters are industry-related.
- Related parties
- BlackRock (>5%) receives $0.55M for clearing consulting — market terms.
How the score works · checked as of Sep 2026
CME Group (CME) earnings: FAQ
How does CME Group make money?
CME Group brought in $1.71 billion of revenue in Q2 2026, up 0.8% year over year. The largest source was Clearing & Transaction Fees: $1.35 billion, or 79% of the total, followed by Market Data & Information ($238M, 14%); other lines add the remaining 7%. Net income for the quarter was $1.04 billion, up 1.6% year over year.
When is CME's next earnings date?
CME Group (CME) is scheduled to report on Oct 21, 2026, before market open.
What time does CME report earnings?
CME Group is scheduled to report before market open on Oct 21, 2026. Its last results releases were filed before market open, most recently at 7:15 am ET on Jul 22, 2026.
When did CME last report earnings?
CME Group reported Q2 2026 results on Jul 24, 2026.
What is the EPS estimate for CME's next earnings?
The consensus EPS forecast is $2.96 (7 analysts), vs $2.68 in the same quarter last year.
Where can I find CME Group's financial statements?
On SEC EDGAR: quarterly reports (10-Q), the annual report (10-K) and earnings releases (8-K). The “Verified” badge next to the chart links to CME's filings; this page breaks the latest report down in a Sankey chart.
What was CME's net income in Q2 2026?
CME Group reported net income of $1,042M for Q2 2026 (+1.6% year over year), under US GAAP.
Does CME Group pay dividends?
Yes. In 2025, CME Group paid $3,933M in dividends on its common stock, per its 10-K. Earlier years are in the five-year table above.
New to earnings reports? Start with how to read an earnings report.
How this page was made: the figures come from the company's own report on SEC EDGAR; the summary and nuances were drafted by our model from that report. Figures checked against the filing on 08/26/2026. How we make the breakdowns · Report an error
More reports: COF · Q2 2026 · GS · Q2 2026 · HOOD · Q2 2026 · ICE · Q2 2026 · JPM · Q2 2026 · KKR · Q2 2026 · MA · Q2 2026 · MCO · Q2 2026 · MS · Q2 2026 · PGR · Q2 2026 · all reports